NAT10 and neoplasm: Consistent with these observations in tumor growth, sh-NAT10-derived xenografts showed reduced number of Ki67 positive cells compared with sh-NC controls (Fig. 7E), supporting the suppression of NAT10 silencing on tumor growth.